Last 12 months
Inside the activity.
4 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 3 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 6, 2026 20:02 UTC |
Kaye MarkEVP & CFO
|
GrantCommon Stock | 2,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001748691-26-000005 · wk-form4_1791316964.xml · nonDerivative · entry 2 Kaye Mark · CIK 0001748691 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,503 F2 · shares: Represents performance based restricted share units. Restrictions lapsed on 10/2/2026. Read SEC document |
| October 02, 2026 Filed Oct 6, 2026 20:02 UTC |
Kaye MarkEVP & CFO
|
Tax withholdingCommon Stock | 4,161 | $386.43 | $1,607,935.23 |
DisclosureSEC source: 0001748691-26-000005 · wk-form4_1791316964.xml · nonDerivative · entry 1 Kaye Mark · CIK 0001748691 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,876 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:06 UTC |
Wessling Erin MEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 255 | $414.78 | $105,768.90 |
DisclosureSEC source: 0002084548-26-000005 · wk-form4_1788552374.xml · nonDerivative · entry 2 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,230 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:06 UTC |
Wessling Erin MEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 94 | $405.84 | $38,148.96 |
DisclosureSEC source: 0002084548-26-000005 · wk-form4_1788552374.xml · nonDerivative · entry 1 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,485 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:05 UTC |
Craig Ryan REVP & Chief HR Officer
|
Tax withholdingCommon Stock | 144 | $405.84 | $58,440.96 |
DisclosureSEC source: 0002084547-26-000009 · wk-form4_1788552323.xml · nonDerivative · entry 1 Craig Ryan R · CIK 0002084547 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,530 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| July 17, 2026 Filed Jul 17, 2026 19:04 UTC |
PERU RAMIRO GDirector
|
PurchaseCommon Stock | 1,000 | $366.05 | $366,050.00 |
DisclosureSEC source: 0001192045-26-000004 · wk-form4_1784315092.xml · nonDerivative · entry 1 PERU RAMIRO G · CIK 0001192045 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,908 Read SEC document |
| July 17, 2026 Filed Jul 17, 2026 17:50 UTC |
BOUDREAUX GAILDirector · President and CEO
|
PurchaseCommon Stock | 2,045 | $368.25 | $753,071.25 |
DisclosureSEC source: 0001287920-26-000006 · wk-form4_1784310641.xml · nonDerivative · entry 2 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,976 F2 · price: This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 17, 2026 Filed Jul 17, 2026 17:50 UTC |
BOUDREAUX GAILDirector · President and CEO
|
PurchaseCommon Stock | 680 | $366.41 | $249,158.80 |
DisclosureSEC source: 0001287920-26-000006 · wk-form4_1784310641.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,931 F1 · price: This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 20:10 UTC |
Penczek Ronald WCAO & Controller
|
SaleCommon Stock | 369 | $403.16 | $148,766.04 |
DisclosureSEC source: 0001659075-26-000006 · wk-form4_1781554242.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,740 F1 · price: This transaction was executed in multiple trades at prices ranging from $403.15 to $403.31. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 20:12 UTC |
Dixon Robert L JRDirector
|
SaleCommon Stock | 151 | $401.77 | $60,667.27 |
DisclosureSEC source: 0001524849-26-000004 · wk-form4_1781295167.xml · nonDerivative · entry 1 Dixon Robert L JR · CIK 0001524849 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,734 Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:11 UTC |
Penczek Ronald WCAO & Controller
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 877 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001659075-26-000004 · wk-form4_1779307888.xml · derivative · entry 5 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 877 shares Expires 2031-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:11 UTC |
Penczek Ronald WCAO & Controller
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 654 | $0.00 Strike: $271.27 | $0.00 |
DisclosureSEC source: 0001659075-26-000004 · wk-form4_1779307888.xml · derivative · entry 4 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 654 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:11 UTC |
Penczek Ronald WCAO & Controller
|
SaleCommon Stock | 1,531 | $403.13 | $617,192.03 |
DisclosureSEC source: 0001659075-26-000004 · wk-form4_1779307888.xml · nonDerivative · entry 3 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,109 F2 · price: This transaction was executed in multiple trades, each at the same price of $403.13. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:11 UTC |
Penczek Ronald WCAO & Controller
|
Exercise / conversionCommon Stock | 877 | $311.48 | $273,167.96 |
DisclosureSEC source: 0001659075-26-000004 · wk-form4_1779307888.xml · nonDerivative · entry 2 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:11 UTC |
Penczek Ronald WCAO & Controller
|
Exercise / conversionCommon Stock | 654 | $271.27 | $177,410.58 |
DisclosureSEC source: 0001659075-26-000004 · wk-form4_1779307888.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:33 UTC |
STRABLE-SOETHOUT DEANNA DDirector
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035643 · wk-form4_1778877227.xml · nonDerivative · entry 1 STRABLE-SOETHOUT DEANNA D · CIK 0001278726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,209 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:16 UTC |
SCHULMAN AMY WDirector
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001438226-26-000009 · wk-form4_1778876180.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 781 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:15 UTC |
Schneider Ryan M.Director
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001420501-26-000004 · wk-form4_1778876145.xml · nonDerivative · entry 1 Schneider Ryan M. · CIK 0001420501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,163 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:15 UTC |
PERU RAMIRO GDirector
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001192045-26-000002 · wk-form4_1778876111.xml · nonDerivative · entry 1 PERU RAMIRO G · CIK 0001192045 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,908 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:14 UTC |
Neri Antonio FDirector
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001648401-26-000006 · wk-form4_1778876082.xml · nonDerivative · entry 1 Neri Antonio F · CIK 0001648401 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,488 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:14 UTC |
Jallal BahijaDirector
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001730038-26-000004 · wk-form4_1778876036.xml · nonDerivative · entry 1 Jallal Bahija · CIK 0001730038 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,351 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:12 UTC |
HAY LEWIS IIIDirector
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001182705-26-000004 · wk-form4_1778875959.xml · nonDerivative · entry 1 HAY LEWIS III · CIK 0001182705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,070 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:12 UTC |
Dixon Robert L JRDirector
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001524849-26-000002 · wk-form4_1778875932.xml · nonDerivative · entry 1 Dixon Robert L JR · CIK 0001524849 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,885 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:11 UTC |
DeVore Susan D.Director
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001587697-26-000006 · wk-form4_1778875890.xml · nonDerivative · entry 1 DeVore Susan D. · CIK 0001587697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,065 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:10 UTC |
COLLIS STEVEN HDirector
|
GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001191508-26-000004 · wk-form4_1778875844.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,202 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| March 12, 2026 Filed Mar 23, 2026 20:10 UTC |
SCHULMAN AMY WDirector
|
SaleCommon Stock | 26 | $287.50 | $7,475.00 |
DisclosureSEC source: 0001438226-26-000007 · wk-form4_1774296634.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218 Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 20:45 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
SaleCommon Stock | 3,196 | $284.92 | $910,604.32 |
DisclosureSEC source: 0001887908-26-000005 · wk-form4_1773089106.xml · nonDerivative · entry 1 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,791 F1 · price: This transaction was executed in multiple trades at prices ranging from $284.82 to $285.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 13:03 UTC |
COLLIS STEVEN HDirector
|
PurchaseCommon Stock | 3,000 | $289.84 | $869,520.00 |
DisclosureSEC source: 0001191508-26-000002 · wk-form4_1772802204.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,639 Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 22:00 UTC |
Penczek Ronald WCAO & Controller
|
Tax withholdingCommon Stock | 37 | $284.03 | $10,509.11 |
DisclosureSEC source: 0001659075-26-000002 · wk-form4_1772661603.xml · nonDerivative · entry 5 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,099 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:59 UTC |
Wessling Erin MEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 417 | $284.03 | $118,440.51 |
DisclosureSEC source: 0002084548-26-000002 · wk-form4_1772661583.xml · nonDerivative · entry 2 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,579 F2 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:59 UTC |
Craig Ryan REVP & Chief HR Officer
|
Tax withholdingCommon Stock | 309 | $284.03 | $87,765.27 |
DisclosureSEC source: 0002084547-26-000005 · wk-form4_1772661549.xml · nonDerivative · entry 3 Craig Ryan R · CIK 0002084547 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,674 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:58 UTC |
Norwood Felicia FEVP &Chief Health Benefits Ofr
|
Tax withholdingCommon Stock | 496 | $284.03 | $140,878.88 |
DisclosureSEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · nonDerivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,838 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:58 UTC |
LAVU RATNAKAREVP & Chief Digital Info Ofr
|
Tax withholdingCommon Stock | 222 | $284.03 | $63,054.66 |
DisclosureSEC source: 0001737620-26-000002 · wk-form4_1772661505.xml · nonDerivative · entry 4 LAVU RATNAKAR · CIK 0001737620 · EVP & Chief Digital Info Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,149 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:58 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
Tax withholdingCommon Stock | 467 | $284.03 | $132,642.01 |
DisclosureSEC source: 0001887908-26-000002 · wk-form4_1772661487.xml · nonDerivative · entry 4 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,987 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:57 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
Tax withholdingCommon Stock | 446 | $284.03 | $126,677.38 |
DisclosureSEC source: 0001608538-26-000002 · wk-form4_1772661470.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,222 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:57 UTC |
Kaye MarkEVP & CFO
|
Tax withholdingCommon Stock | 353 | $284.03 | $100,262.59 |
DisclosureSEC source: 0001748691-26-000002 · wk-form4_1772661447.xml · nonDerivative · entry 4 Kaye Mark · CIK 0001748691 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,037 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:56 UTC |
BOUDREAUX GAILDirector · President and CEO
|
Tax withholdingCommon Stock | 1,736 | $284.03 | $493,076.08 |
DisclosureSEC source: 0001287920-26-000002 · wk-form4_1772661402.xml · nonDerivative · entry 4 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,251 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 22:00 UTC |
Penczek Ronald WCAO & Controller
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,677 | $0.00 Strike: $294.07 | $0.00 |
DisclosureSEC source: 0001659075-26-000002 · wk-form4_1772661603.xml · derivative · entry 6 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,677 Underlying: Common Stock · 1,677 shares Expires 2036-03-02 F6 · derivative.exercise_date: The option represents a right to purchase a total of 1,677 shares, and is exercisable in three annual installments, each installment of 559 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 22:00 UTC |
Penczek Ronald WCAO & Controller
|
GrantCommon Stock | 266 | $0.00 | $0.00 |
DisclosureSEC source: 0001659075-26-000002 · wk-form4_1772661603.xml · nonDerivative · entry 4 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,136 F5 · shares: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 22:00 UTC |
Penczek Ronald WCAO & Controller
|
GrantCommon Stock | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001659075-26-000002 · wk-form4_1772661603.xml · nonDerivative · entry 3 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,870 F4 · shares: Represents restricted share units. Restrictions lapse as follows: 850 shares on 3/2/2027, and 851 shares on 3/2/2028. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 22:00 UTC |
Penczek Ronald WCAO & Controller
|
GrantCommon Stock | 426 | $0.00 | $0.00 |
DisclosureSEC source: 0001659075-26-000002 · wk-form4_1772661603.xml · nonDerivative · entry 2 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,169 F3 · shares: Represents restricted share units. Restrictions lapse as follows: 142 shares on 3/2/2027, 3/2/2028 and 3/2/2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 22:00 UTC |
Penczek Ronald WCAO & Controller
|
Tax withholdingCommon Stock | 131 | $294.07 | $38,523.17 |
DisclosureSEC source: 0001659075-26-000002 · wk-form4_1772661603.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,743 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. F2 · balance_after: Balance includes 7.06 shares acquired on March 25, 2025, 6.14 shares acquired on June 25, 2025, 7.18 shares acquired on September 25, 2025 and 6.85 shares acquired on December 19, 2025 through a dividend reinvestment plan. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:59 UTC |
Wessling Erin MEVP & Chief Legal Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,754 | $0.00 Strike: $294.07 | $0.00 |
DisclosureSEC source: 0002084548-26-000002 · wk-form4_1772661583.xml · derivative · entry 3 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,754 Underlying: Common Stock · 11,754 shares Expires 2036-03-02 F3 · derivative.exercise_date: The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:59 UTC |
Wessling Erin MEVP & Chief Legal Officer
|
GrantCommon Stock | 2,976 | $0.00 | $0.00 |
DisclosureSEC source: 0002084548-26-000002 · wk-form4_1772661583.xml · nonDerivative · entry 1 Wessling Erin M · CIK 0002084548 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,996 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:59 UTC |
Craig Ryan REVP & Chief HR Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,754 | $0.00 Strike: $294.07 | $0.00 |
DisclosureSEC source: 0002084547-26-000005 · wk-form4_1772661549.xml · derivative · entry 4 Craig Ryan R · CIK 0002084547 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,754 Underlying: Common Stock · 11,754 shares Expires not disclosed F3 · derivative.expiration_date: The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:59 UTC |
Craig Ryan REVP & Chief HR Officer
|
GrantCommon Stock | 2,976 | $0.00 | $0.00 |
DisclosureSEC source: 0002084547-26-000005 · wk-form4_1772661549.xml · nonDerivative · entry 2 Craig Ryan R · CIK 0002084547 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,983 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:59 UTC |
Craig Ryan REVP & Chief HR Officer
|
Tax withholdingCommon Stock | 25 | $294.07 | $7,351.75 |
DisclosureSEC source: 0002084547-26-000005 · wk-form4_1772661549.xml · nonDerivative · entry 1 Craig Ryan R · CIK 0002084547 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,007 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:58 UTC |
Norwood Felicia FEVP &Chief Health Benefits Ofr
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 23,512 | $0.00 Strike: $294.07 | $0.00 |
DisclosureSEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · derivative · entry 5 Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,512 Underlying: Common Stock · 23,512 shares Expires 2036-03-02 F4 · derivative.exercise_date: The option represents a right to purchase a total of 23,512 shares, and is exercisable in two installments of 7,837 shares each and one installment of 7,838 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:58 UTC |
Norwood Felicia FEVP &Chief Health Benefits Ofr
|
GrantCommon Stock | 2,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,334 F3 · shares: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:58 UTC |
Norwood Felicia FEVP &Chief Health Benefits Ofr
|
GrantCommon Stock | 5,951 | $0.00 | $0.00 |
DisclosureSEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,469 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,983 shares on 3/2/2027, and 1,984 shares each on 3/2/2028 and 3/2/2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.